Operating Expenses Summary of ModivCare Inc.

ModivCare Inc.'s latest annual operating expenses in 2023 was 586.89 Million USD , down -26.65% from previous year.
ModivCare Inc.'s latest quarterly operating expenses in 2024 Q2 was 76.06 Million USD , down -1.44% from previous quarter.
ModivCare Inc. reported a annual operating expenses of 415.23 Million USD in annual operating expenses 2022, up 28.63% from previous year.
ModivCare Inc. reported a annual operating expenses of 322.82 Million USD in annual operating expenses 2021, up 93.63% from previous year.
ModivCare Inc. reported a quarterly operating expenses of 76.06 Million USD for 2024 Q2, down -1.44% from previous quarter.
ModivCare Inc. reported a quarterly operating expenses of 95.66 Million USD for 2023 Q3, down -6.68% from previous quarter.

Annual Operating Expenses Chart of ModivCare Inc. (2023 - 2001)

Historical Annual Operating Expenses of ModivCare Inc. (2023 - 2001)

Year	Operating Expenses	Operating Expenses Growth
2023	586.89 Million USD	-26.65%
2022	415.23 Million USD	28.63%
2021	322.82 Million USD	93.63%
2020	166.72 Million USD	98.34%
2019	84.06 Million USD	35.78%
2018	61.91 Million USD	-37.34%
2017	98.8 Million USD	2.37%
2016	96.51 Million USD	-24.05%
2015	127.08 Million USD	36.47%
2014	93.12 Million USD	46.64%
2013	63.5 Million USD	-7.16%
2012	68.4 Million USD	9.42%
2011	62.51 Million USD	5.76%
2010	59.11 Million USD	3.96%
2009	56.86 Million USD	-6.99%
2008	61.13 Million USD	70.46%
2007	35.86 Million USD	33.33%
2006	26.89 Million USD	32.69%
2005	20.27 Million USD	50.82%
2004	13.44 Million USD	91.38%
2003	7.02 Million USD	1085.7%
2002	-712.55 Thousand USD	-100.03%
2001	2.45 Billion USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	77.17 Million USD	-88.77%
2024 Q2	76.06 Million USD	-1.44%
2023 Q3	95.66 Million USD	-6.68%
2023 Q4	687.54 Million USD	618.68%
2023 FY	304.56 Million USD	-26.65%
2023 Q1	103.94 Million USD	-8.29%
2023 Q2	102.51 Million USD	-1.37%
2022 Q3	100.77 Million USD	-0.07%
2022 Q4	113.33 Million USD	12.47%
2022 FY	415.23 Million USD	28.63%
2022 Q2	100.83 Million USD	0.55%
2022 Q1	100.28 Million USD	-9.15%
2021 Q3	80.66 Million USD	19.83%
2021 Q1	64.46 Million USD	2.18%
2021 FY	322.82 Million USD	93.63%
2021 Q2	67.31 Million USD	4.42%
2021 Q4	110.38 Million USD	36.85%
2020 FY	166.72 Million USD	98.34%
2020 Q1	24.58 Million USD	30.47%
2020 Q2	37.3 Million USD	51.75%
2020 Q3	41.74 Million USD	11.89%
2020 Q4	63.08 Million USD	51.14%
2019 Q3	20.12 Million USD	-5.12%
2019 FY	84.06 Million USD	35.78%
2019 Q1	23.87 Million USD	26.46%
2019 Q2	21.21 Million USD	-11.15%
2019 Q4	18.84 Million USD	-6.38%
2018 Q2	26.15 Million USD	3.75%
2018 Q4	18.88 Million USD	-17.35%
2018 FY	61.91 Million USD	-37.34%
2018 Q1	25.21 Million USD	-0.68%
2018 Q3	22.84 Million USD	-12.66%
2017 Q2	24.94 Million USD	7.09%
2017 FY	98.8 Million USD	2.37%
2017 Q4	25.38 Million USD	0.83%
2017 Q3	25.17 Million USD	0.91%
2017 Q1	23.29 Million USD	-2.56%
2016 FY	96.51 Million USD	-24.05%
2016 Q4	23.9 Million USD	-0.34%
2016 Q3	23.99 Million USD	-25.47%
2016 Q2	32.18 Million USD	-3.94%
2016 Q1	33.5 Million USD	18.04%
2015 Q3	34.69 Million USD	-9.35%
2015 Q2	38.27 Million USD	-3.31%
2015 Q1	39.58 Million USD	86.06%
2015 FY	127.08 Million USD	36.47%
2015 Q4	28.38 Million USD	-18.18%
2014 Q1	17.34 Million USD	8.06%
2014 Q2	21.3 Million USD	22.84%
2014 Q3	33.13 Million USD	55.51%
2014 Q4	21.27 Million USD	-35.79%
2014 FY	93.12 Million USD	46.64%
2013 Q3	14.8 Million USD	-10.07%
2013 Q2	16.46 Million USD	1.76%
2013 FY	63.5 Million USD	-7.16%
2013 Q4	16.05 Million USD	8.4%
2013 Q1	16.18 Million USD	-12.78%
2012 Q3	18.59 Million USD	6.85%
2012 Q4	18.55 Million USD	-0.22%
2012 FY	68.4 Million USD	9.42%
2012 Q1	16.36 Million USD	5.51%
2012 Q2	17.4 Million USD	6.33%
2011 Q3	16.09 Million USD	2.23%
2011 Q1	15.17 Million USD	1.52%
2011 Q2	15.74 Million USD	3.75%
2011 Q4	15.51 Million USD	-3.62%
2011 FY	62.51 Million USD	5.76%
2010 Q4	14.94 Million USD	-2.62%
2010 Q2	14.9 Million USD	7.13%
2010 Q3	15.34 Million USD	2.96%
2010 Q1	13.91 Million USD	-0.33%
2010 FY	59.11 Million USD	3.96%
2009 FY	56.86 Million USD	-6.99%
2009 Q1	14.97 Million USD	112.33%
2009 Q4	13.96 Million USD	-5.5%
2009 Q3	14.77 Million USD	12.32%
2009 Q2	13.15 Million USD	-12.17%
2008 FY	61.13 Million USD	70.46%
2008 Q4	-121.49 Million USD	-178.7%
2008 Q3	154.37 Million USD	1063.75%
2008 Q2	13.26 Million USD	-11.48%
2008 Q1	14.98 Million USD	37.76%
2007 Q1	8.32 Million USD	11.77%
2007 Q2	8.68 Million USD	4.33%
2007 FY	35.86 Million USD	33.33%
2007 Q3	7.97 Million USD	-8.22%
2007 Q4	10.87 Million USD	36.45%
2006 Q2	6.9 Million USD	11.68%
2006 Q1	6.18 Million USD	-2.91%
2006 Q4	7.44 Million USD	17.03%
2006 FY	26.89 Million USD	32.69%
2006 Q3	6.36 Million USD	-7.8%
2005 Q1	4.32 Million USD	23.53%
2005 Q2	34.62 Million USD	699.59%
2005 Q3	8.98 Million USD	-74.04%
2005 Q4	6.36 Million USD	-29.17%
2005 FY	20.27 Million USD	50.82%
2004 Q2	3.09 Million USD	10.8%
2004 FY	13.44 Million USD	91.38%
2004 Q1	2.79 Million USD	43.06%
2004 Q4	3.5 Million USD	-13.51%
2004 Q3	4.05 Million USD	31.03%
2003 Q4	1.95 Million USD	11.5%
2003 FY	7.02 Million USD	1085.7%
2003 Q3	1.74 Million USD	-3.25%
2003 Q2	1.8 Million USD	0.0%
2003 Q1	- USD	0.0%
2002 FY	-712.55 Thousand USD	-100.03%
2001 Q3	479.93 Million USD	7.19%
2001 Q4	557.53 Million USD	16.17%
2001 FY	2.45 Billion USD	0.0%
2001 Q2	447.73 Million USD	0.0%

Peer Operating Expenses Comparison of ModivCare Inc.

Name	Operating Expenses	Operating Expenses Difference
Acadia Healthcare Company, Inc.	176.01 Million USD	-233.44%
Addus HomeCare Corporation	248.92 Million USD	-135.778%
AirSculpt Technologies, Inc.	118.32 Million USD	-396.018%
Amedisys, Inc.	834.47 Million USD	29.669%
American Oncology Network, Inc.	83.97 Million USD	-598.896%
Astrana Health, Inc.	112.59 Million USD	-421.238%
Aveanna Healthcare Holdings Inc.	587.36 Million USD	0.079%
IMAC Holdings, Inc.	5.02 Million USD	-11574.623%
biote Corp.	98.82 Million USD	-493.87%
Cryo-Cell International, Inc.	35.2 Million USD	-1567.067%
Cross Country Healthcare, Inc.	337.69 Million USD	-73.794%
COMPASS Pathways plc	136.91 Million USD	-328.646%
DocGo Inc.	180.32 Million USD	-225.462%
The Ensign Group, Inc.	335.39 Million USD	-74.989%
Healthcare Services Group, Inc.	189.09 Million USD	-210.377%
InnovAge Holding Corp.	558.25 Million USD	-5.131%
Assure Holdings Corp.	15.43 Million USD	-3701.399%
The Joint Corp.	109.22 Million USD	-437.34%
LifeStance Health Group, Inc.	491.23 Million USD	-19.475%
Mobile-health Network Solutions Class A Ordinary Shares	18.24 Million USD	-3117.269%
NewGenIvf Group Limited	1.63 Million USD	-35696.438%
Novo Integrated Sciences, Inc.	13.5 Million USD	-4245.501%
Option Care Health, Inc.	666.62 Million USD	11.96%
P3 Health Partners Inc.	199.56 Million USD	-194.089%
P3 Health Partners Inc.	199.56 Million USD	-194.089%
The Pennant Group, Inc.	88.99 Million USD	-559.473%
Surgery Partners, Inc.	319.5 Million USD	-83.693%
Syra Health Corp. Class A Common Stock	4.29 Million USD	-13550.381%
Talkspace, Inc.	97.58 Million USD	-501.398%
Talkspace, Inc.	97.58 Million USD	-501.398%
The Oncology Institute, Inc.	136.59 Million USD	-329.675%
The Oncology Institute, Inc.	136.59 Million USD	-329.675%

Global Stocks Search

ModivCare Inc. (MODV)

Operating Expenses Summary of ModivCare Inc.

Annual Operating Expenses Chart of ModivCare Inc. (2023 - 2001)

Historical Annual Operating Expenses of ModivCare Inc. (2023 - 2001)

Peer Operating Expenses Comparison of ModivCare Inc.